期刊文献+

上皮性卵巢癌预后因素分析 被引量:9

Prognosis factor in epithelial ovarian cancer
暂未订购
导出
摘要 目的探讨影响上皮性卵巢癌预后的因素,为临床治疗提供依据。方法回顾分析1999年1月至2000年12月青岛大学医学院附属医院收治的100例卵巢癌患者的完整临床资料,用SPSS10.0软件进行Kaplan-Meier单因素和Cox多因素生存分析。计算各因素的风险系数并转化为评分,以评分计算生存概率。结果临床病理分期较早,细胞高分化,病理类型为子宫内膜样腺癌,无淋巴结转移,手术残余病灶≤2cm,术后规范化疗的患者预后较好。结论临床病理分期、病理分级、淋巴结转移情况、手术残余病灶大小、术后化疗情况、病理类型均是预测卵巢癌预后的独立因素。分析相关因素,并计算评分,可以预测卵巢癌患者的生存概率。 Objective:To explore the prognostic factors for epithelial ovarian tumors,in order to provide guidance for clinical therapy. Methods:The complete clinical data of 100 patients with epithelial ovarian carcinoma in from January 1999 to December 2000 were analyzed retrospectively and Kaplan-Meier survival analysis and Cox multiple factor survival analysis were conducted with SPSS10.0. The risk coefficient of each factor was calculated and trans- formed to score, then the survival probability was calculated with the score. Results:Patients with early clinical-pathology stage, high pathology grading, endometrioid adenocarcinom in pathology type, no lymphnode metastasis ,less than 2cm residuals and adjuvent chemotherapy after operation had better prognosis. Conclusion: Clinical-pathology staging, patho-grading, the status of lymphnode metastasis, the size of the residuals, adjuvent chemotherapy and patho-type are independent prognostic factor of epithelial ovarian cancer. It is possible to estimate the prognosis of patients with ovarian cancer by analyzing these factors and calculated score.
出处 《现代妇产科进展》 CSCD 北大核心 2007年第4期285-288,293,共5页 Progress in Obstetrics and Gynecology
关键词 卵巢肿瘤 外科手术 药物疗法 病理 临床 预后 Ovarian neoplasms Surgical procedures, operative Drug therapy Pathology, clinical Prognosis
  • 相关文献

参考文献12

  • 1赵晓东,张毅.晚期卵巢上皮癌化疗的用药剂量[J].国外医学(妇产科学分册),2005,32(4):235-238. 被引量:4
  • 2曹泽毅.中华妇产科学[M].北京:人民卫生出版社,1999.2129.
  • 3高显忠,许树旭,主编.现代肿瘤诊断治疗学[M].北京:科学技术文献出版社,2005.323-332
  • 4李艳芳,李孟达,李俊东,刘富元,刘继红.卵巢上皮性癌复发规律的探讨[J].癌症,2000,19(6):600-602. 被引量:18
  • 5刘穗,刘继红,黄鹤,彭小萍,王园美.上皮性卵巢癌复发的影响因素分析[J].癌症,2003,22(11):1197-1200. 被引量:10
  • 6Kikkawa F,Ishikawa H,Tamakoshi K,et al.Prognostic evaluation of lymphadenctomy for epithelial ovarian cancer[J].J Surg Oncol,1995,60:227-231
  • 7Agarwal R,Kaye SB.Ovarian cancer:strategies for overconfing resistance to chemotherapy[J].Nat Rev Cancer,2003,3:502-516
  • 8汤洁,蔡树模,臧荣余,王华英.Ⅲ期卵巢癌减灭术后腹腔残瘤对患者预后的影响[J].中国癌症杂志,2004,14(1):31-35. 被引量:5
  • 9Bristow RE,Tomacruz RS,Armstrong DK,et al.Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era:a meta-analysis[J].J Clin Oncol,2002,20:1248-1259
  • 10Brun JL,Feyler A,Chene G,et al.Long-term results and prognostic factor in patients with epithelial ovarian cancer[J].Gynecol Oncol,2000,78:21-27

二级参考文献54

  • 1卢丹,王志学,陶晓珏.卵巢癌组织中多药耐药基因蛋白表达及其临床价值[J].肿瘤防治杂志,2004,11(5):512-514. 被引量:15
  • 2李孟达,黄欣.中、晚期卵巢癌综合治疗疗效及影响因素的分析[J].中华妇产科杂志,1996,31(10):621-623. 被引量:35
  • 3[3]Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta- analysis. J Clin Oncol, 2002, 20: 1248-1259.
  • 4[5]Eisenkop SM, Friedman RL, Wang HJ, et al. Complete cytoreductive surgery is feasible and msximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol, 1998,69:103 - 108.
  • 5[6]Morice P, Dubernard G, Rey A, et al. Results of interval debulking surgery in advanced stage ovarian cancer. J Am Coll Surg, 2003, 197:955 - 963.
  • 6[7]FanfaniF, Ferrandina G, Corrado G, et al. Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage Ⅲ c ovarian cancer patients. Oncology, 2003, 65: 316-322.
  • 7[8]Brun JL, Feyler A, Chene G, et al. Long- term results and prognostic factor in patients with epithelial ovarian cancer. Gynecol Oncol,2000, 78: 21-27.
  • 8Vrscaj MU, Rakar S. Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: a retrospective case-control study [J]. Eur J Gynaecol Oncol,2002,23(5): 405- 410.
  • 9Hatae M, Onishi Y, Nakamura T, et al. Neoadjuvent chemotherapy for advanced epithelial cancer[J]. Gan To Kagaku Ryoho, 2001, 28(12): 1833 - 1837.
  • 10Rubin SC, Hoskins W J, Saigo PE, et al. Prognostic factors for recurrence following negative second-look laparoctomy in ovarian cancer patients treated with platinum-based chemotherapy[J]. Gynecol Oncol, 1991,42:137 -141.

共引文献3272

同被引文献97

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部